This may result in an overrepresentation of families carrying a stronger cancer risk with possibly an earlier age of occurrence; however, this appears not to be the case as regards MLH1 mutation carriers as in the population-based Australian National Endometrial Cancer Study, no MLH1-LS cases were found in EC patients above 60 years of age [14]. This evidence concerns the gene MLH1 and cancer.